Sprint Bioscience AB had a revenue of 16.27M in the quarter ending Dec 31, 2024, with 9.88%. This bring the company's revenue in the last twelve months to 65.64M, Decreased 8.94%. In the fiscal year ending Dec 31, 2024, Sprint Bioscience AB had annual revenue of 65.64M with 30.02% growth.